Anthony Lawrie

A Performance Evaluation of Commercial Fibrinogen Reference Preparations and Assays for Clauss and PT-derived Fibrinogen

G. Lowe, P. Gaffney, P. Rigsby, 2002, Thrombosis and Haemostasis.

A comparative evaluation of a new automated assay for von Willebrand factor activity

M. Canciani, F. Stufano, Samuel J. Machin, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

The effect of prion reduction in solvent/detergent‐treated plasma on haemostatic variables

M. Canciani, Samuel J. Machin, Ian J. Mackie, 2010, Vox sanguinis.

An international collaborative study to compare different von Willebrand factor glycoprotein Ib binding activity assays: the COMPASS‐VWF study

R. Montgomery, G. Castaman, F. Peyvandi, 2018, Journal of thrombosis and haemostasis : JTH.

Evaluation of an automated platelet‐based assay of ristocetin cofactor activity

Samuel J. Machin, Anthony Lawrie, I. J. Mackie, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

von Willebrand factor‐cleaving protease activity in congenital thrombotic thrombocytopenic purpura

R. Liesner, I. Mackie, S. Machin, 2000, British journal of haematology.

Changes in factor XIII level during pregnancy

R. Kadir, C. Smith, L. Sharief, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

The VWF/ADAMTS13 axis in the antiphospholipid syndrome: ADAMTS13 antibodies and ADAMTS13 dysfunction

S. Austin, H. Cohen, I. Mackie, 2008, British journal of haematology.

Factor XIII – an under diagnosed deficiency – are we using the right assays?

R. Liesner, Ian J. Mackie, Anthony Lawrie, 2010, Journal of thrombosis and haemostasis : JTH.

Rivaroxaban and warfarin achieve effective anticoagulation, as assessed by inhibition of TG and in-vivo markers of coagulation activation, in patients with venous thromboembolism.

H. Cohen, S. Machin, I. Mackie, 2015, Thrombosis research.